Gregory P Bisson

Summary

Publications

  1. ncbi Effect of GB virus C viremia on HIV acquisition and HIV set-point
    Gregory P Bisson
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 19:1910-2. 2005
  2. ncbi Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104 6021, USA
    AIDS 20:1613-9. 2006
  3. ncbi Overestimates of survival after HAART: implications for global scale-up efforts
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    PLoS ONE 3:e1725. 2008
  4. ncbi Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
    PLoS Med 5:e109. 2008
  5. ncbi Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana
    Gregory P Bisson
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Acquir Immune Defic Syndr 49:107-10. 2008
  6. ncbi The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana
    Gregory P Bisson
    Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 49:227-9. 2008
  7. ncbi Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector
    Gregory P Bisson
    Division of Infectious Disease, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 20:1333-6. 2006
  8. ncbi Isoniazid-resistant tuberculous meningitis, United States, 1993-2005
    Christopher Vinnard
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Emerg Infect Dis 17:539-42. 2011
  9. ncbi Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana
    Katherine T Steele
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
    PLoS ONE 6:e20010. 2011
  10. ncbi Lost but not forgotten--the economics of improving patient retention in AIDS treatment programs
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Department of Medicine, Division of Infectious Diseases, Philadelphia, Pennsylvania, USA
    PLoS Med 6:e1000174. 2009

Collaborators

Detail Information

Publications14

  1. ncbi Effect of GB virus C viremia on HIV acquisition and HIV set-point
    Gregory P Bisson
    Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 19:1910-2. 2005
    ..32; 95% confidence interval 0.6-2.6). Pre-existing GBV-C viremia at the time of HIV acquisition was also not associated with lower plasma HIV-RNA levels...
  2. ncbi Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania19104 6021, USA
    AIDS 20:1613-9. 2006
    ..To derive and internally validate a clinical prediction rule for virologic response based on CD4 cell count increase after initiation of HAART in a resource-limited setting...
  3. ncbi Overestimates of survival after HAART: implications for global scale-up efforts
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    PLoS ONE 3:e1725. 2008
    ..Determining definitive outcomes of these lost patients, and the effects of losses to follow-up on estimates of survival and risk factors for death after HAART, are key to monitoring the effectiveness of global HAART scale-up efforts...
  4. ncbi Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
    Gregory P Bisson
    Department of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
    PLoS Med 5:e109. 2008
    ....
  5. ncbi Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana
    Gregory P Bisson
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    J Acquir Immune Defic Syndr 49:107-10. 2008
    ..Although adherence to antiretroviral therapy may be higher in sub-Saharan Africa, knowledge regarding the magnitude of adherence needed to maintain virological suppression in this setting is limited...
  6. ncbi The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana
    Gregory P Bisson
    Department of Medicine, University of Pennsylvania School of Medicine, 423 Guardian Drive, Philadelphia, PA 19104, USA
    J Acquir Immune Defic Syndr 49:227-9. 2008
    ..The objective of this study was to evaluate outcomes among adults with a first episode of cryptococcal meningitis (CM), comparing those on highly active antiretroviral therapy (HAART) with those not on HAART...
  7. ncbi Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector
    Gregory P Bisson
    Division of Infectious Disease, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    AIDS 20:1333-6. 2006
    ..001]. HAART costs should be minimized as scale-up efforts in sub-Saharan Africa progress...
  8. ncbi Isoniazid-resistant tuberculous meningitis, United States, 1993-2005
    Christopher Vinnard
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Emerg Infect Dis 17:539-42. 2011
    ..Foreign-born patients were more likely to be infected with an isoniazid-resistant strain...
  9. ncbi Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana
    Katherine T Steele
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
    PLoS ONE 6:e20010. 2011
    ..We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana...
  10. ncbi Lost but not forgotten--the economics of improving patient retention in AIDS treatment programs
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Department of Medicine, Division of Infectious Diseases, Philadelphia, Pennsylvania, USA
    PLoS Med 6:e1000174. 2009
    ..Gregory Bisson and Jeffrey Stringer discuss the implications of a new study showing how loss to follow-up affects the effectiveness of a public sector HIV program in Côte d'Ivoire...
  11. ncbi Cryptococcus and lymphocytic meningitis in Botswana
    Gregory P Bisson
    Infectious Diseases Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    S Afr Med J 98:724-5. 2008
    ..Moreover, almost 70% of CSF samples with significant lymphocytosis did not yield a pathogen, suggesting that many causes of lymphocytic meningitis go undiagnosed...
  12. ncbi Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study
    Christopher Vinnard
    Department of Medicine, Division of Infectious Diseases, University of Pennsylvania School of Medicine, 502 Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA
    BMJ 341:c4451. 2010
    ..To determine whether initial isoniazid resistance is associated with death during the treatment of tuberculous meningitis...
  13. ncbi A simple novel method for determining mortality rates in HIV treatment programs worldwide
    Gregory P Bisson
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    PLoS Med 8:e1000392. 2011
    ....
  14. ncbi Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections
    Zahoor Ahmad
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Antimicrob Agents Chemother 55:1527-32. 2011
    ..Clinical studies are warranted to investigate the sterilizing activity and tolerability of higher doses of pyrazinamide in combination tuberculosis regimens...